Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker MPLT
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Anatol Kreitzer Chief Discovery Officer | MPLT MapLight Therapeutics, Inc. | Sale | 12,248 | $7.84 | $96.0K Sale | Form 4 ↗ |
| Oct 15, 2026 | Erin Pennock Foff Chief Medical Officer | MPLT MapLight Therapeutics, Inc. | Sale | 15,355 | $8.08 | $124.1K Sale | Form 4 ↗ |
| Oct 15, 2026 | Kristopher Hanson General Counsel | MPLT MapLight Therapeutics, Inc. | Sale | 9,020 | $8.08 | $72.9K Sale | Form 4 ↗ |
| Oct 15, 2026 | James Woodruff Lillie Chief Scientific Officer | MPLT MapLight Therapeutics, Inc. | Sale | 11,513 | $8.08 | $93.0K Sale | Form 4 ↗ |
| Oct 15, 2026 | Jonathan Gillis CAO and Interim CFO | MPLT MapLight Therapeutics, Inc. | Sale | 10,167 | $8.08 | $82.1K Sale | Form 4 ↗ |
| Oct 15, 2026 | Christopher A. Kroeger Chief Executive Officer, Director | MPLT MapLight Therapeutics, Inc. | Sale | 73,691 | $8.08 | $595.4K Sale | Form 4 ↗ |
| Sep 16, 2026 | Kristopher Hanson General Counsel | MPLT MapLight Therapeutics, Inc. | Sale | 16,509 | $11.67 | $192.7K Sale | Form 4 ↗ |
| Aug 14, 2026 | Catalyst4, Inc. 10% owner | MLPT MapLight Therapeutics, Inc. | Buy | 4.40M | $11.38 | $50.1M Buy | Form 4 ↗ |
| Aug 3, 2026 | James Woodruff Lillie Chief Scientific Officer | MPLT MapLight Therapeutics, Inc. | Sale | 22,082 | $12.54 | $276.9K Sale | Form 4 ↗ |
| Jul 30, 2026 | Catalyst4, Inc. 10% owner | MLPT MapLight Therapeutics, Inc. | Buy | 1.00M | $13.00 | $13.0M Buy | Form 4 ↗ |
| Jul 29, 2026 | Catalyst4, Inc. 10% owner | MLPT MapLight Therapeutics, Inc. | Buy | 3,000 | $12.63 | $37.9K Buy | Form 4 ↗ |
| Jul 28, 2026 | Catalyst4, Inc. 10% owner | MLPT MapLight Therapeutics, Inc. | Buy | 65,137 | $11.69 | $761.5K Buy | Form 4 ↗ |
| Jul 28, 2026 | Catalyst4, Inc. 10% owner | MLPT MapLight Therapeutics, Inc. | Buy | 141,088 | $10.74 | $1.5M Buy | Form 4 ↗ |
| Jul 28, 2026 | Troy Cox Director | MPLT MapLight Therapeutics, Inc. | Buy | 15,620 | $9.52 | $148.7K Buy | Form 4 ↗ |
| Jul 17, 2026 | Anatol Kreitzer Chief Discovery Officer | MPLT MapLight Therapeutics, Inc. | Sale | 200 | $38.39 | $7,678 Sale | Form 4 ↗ |
| Jul 17, 2026 | Anatol Kreitzer Chief Discovery Officer | MPLT MapLight Therapeutics, Inc. | Sale | 14,140 | $37.70 | $533.1K Sale | Form 4 ↗ |
| Jul 17, 2026 | Anatol Kreitzer Chief Discovery Officer | MPLT MapLight Therapeutics, Inc. | Sale | 2,833 | $37.05 | $105.0K Sale | Form 4 ↗ |
| Jul 17, 2026 | Erin Pennock Foff Chief Medical Officer | MPLT MapLight Therapeutics, Inc. | Sale | 3,656 | $37.90 | $138.6K Sale | Form 4 ↗ |
| Jul 17, 2026 | Kristopher Hanson General Counsel | MPLT MapLight Therapeutics, Inc. | Sale | 1,130 | $37.90 | $42.8K Sale | Form 4 ↗ |
| Jul 17, 2026 | James Woodruff Lillie Chief Scientific Officer | MPLT MapLight Therapeutics, Inc. | Sale | 2,077 | $37.90 | $78.7K Sale | Form 4 ↗ |
| Jul 17, 2026 | Jonathan Gillis CAO and Interim CFO | MPLT MapLight Therapeutics, Inc. | Sale | 900 | $38.17 | $34.4K Sale | Form 4 ↗ |
| Jul 17, 2026 | Jonathan Gillis CAO and Interim CFO | MPLT MapLight Therapeutics, Inc. | Sale | 16,969 | $37.61 | $638.2K Sale | Form 4 ↗ |
| Jul 17, 2026 | Jonathan Gillis CAO and Interim CFO | MPLT MapLight Therapeutics, Inc. | Sale | 600 | $36.51 | $21.9K Sale | Form 4 ↗ |
| Jul 17, 2026 | Christopher A. Kroeger Chief Executive Officer, Director | MPLT MapLight Therapeutics, Inc. | Sale | 16,779 | $37.90 | $635.9K Sale | Form 4 ↗ |
| Jul 16, 2026 | Anatol Kreitzer Chief Discovery Officer | MPLT MapLight Therapeutics, Inc. | Sale | 1,592 | $37.44 | $59.6K Sale | Form 4 ↗ |
| Jul 16, 2026 | Anatol Kreitzer Chief Discovery Officer | MPLT MapLight Therapeutics, Inc. | Sale | 7,464 | $36.66 | $273.6K Sale | Form 4 ↗ |
| Jul 16, 2026 | Erin Pennock Foff Chief Medical Officer | MPLT MapLight Therapeutics, Inc. | Sale | 19 | $37.96 | $721 Sale | Form 4 ↗ |
| Jul 16, 2026 | Erin Pennock Foff Chief Medical Officer | MPLT MapLight Therapeutics, Inc. | Sale | 5,865 | $37.26 | $218.5K Sale | Form 4 ↗ |
| Jul 16, 2026 | Erin Pennock Foff Chief Medical Officer | MPLT MapLight Therapeutics, Inc. | Sale | 9,163 | $36.46 | $334.1K Sale | Form 4 ↗ |
| Jul 16, 2026 | Kristopher Hanson General Counsel | MPLT MapLight Therapeutics, Inc. | Sale | 11 | $37.96 | $418 Sale | Form 4 ↗ |
| Jul 16, 2026 | Kristopher Hanson General Counsel | MPLT MapLight Therapeutics, Inc. | Sale | 3,331 | $37.26 | $124.1K Sale | Form 4 ↗ |
| Jul 16, 2026 | Kristopher Hanson General Counsel | MPLT MapLight Therapeutics, Inc. | Sale | 4,776 | $36.45 | $174.1K Sale | Form 4 ↗ |
| Jul 16, 2026 | James Woodruff Lillie Chief Scientific Officer | MPLT MapLight Therapeutics, Inc. | Sale | 12 | $37.96 | $456 Sale | Form 4 ↗ |
| Jul 16, 2026 | James Woodruff Lillie Chief Scientific Officer | MPLT MapLight Therapeutics, Inc. | Sale | 3,526 | $37.26 | $131.4K Sale | Form 4 ↗ |
| Jul 16, 2026 | James Woodruff Lillie Chief Scientific Officer | MPLT MapLight Therapeutics, Inc. | Sale | 5,009 | $36.45 | $182.6K Sale | Form 4 ↗ |
| Jul 16, 2026 | Jonathan Gillis CAO and Interim CFO | MPLT MapLight Therapeutics, Inc. | Sale | 1,476 | $37.44 | $55.3K Sale | Form 4 ↗ |
| Jul 16, 2026 | Jonathan Gillis CAO and Interim CFO | MPLT MapLight Therapeutics, Inc. | Sale | 6,979 | $36.66 | $255.9K Sale | Form 4 ↗ |
| Jul 16, 2026 | Christopher A. Kroeger Chief Executive Officer, Director | MPLT MapLight Therapeutics, Inc. | Sale | 92 | $37.96 | $3,492 Sale | Form 4 ↗ |
| Jul 16, 2026 | Christopher A. Kroeger Chief Executive Officer, Director | MPLT MapLight Therapeutics, Inc. | Sale | 28,091 | $37.26 | $1.0M Sale | Form 4 ↗ |
| Jul 16, 2026 | Christopher A. Kroeger Chief Executive Officer, Director | MPLT MapLight Therapeutics, Inc. | Sale | 40,899 | $36.46 | $1.5M Sale | Form 4 ↗ |
| Jul 15, 2026 | Anatol Kreitzer Chief Discovery Officer | MPLT MapLight Therapeutics, Inc. | Sale | 4,510 | $36.94 | $166.6K Sale | Form 4 ↗ |
| Jul 15, 2026 | Anatol Kreitzer Chief Discovery Officer | MPLT MapLight Therapeutics, Inc. | Sale | 5,545 | $36.13 | $200.3K Sale | Form 4 ↗ |
| Jul 15, 2026 | Erin Pennock Foff Chief Medical Officer | MPLT MapLight Therapeutics, Inc. | Sale | 18 | $37.54 | $676 Sale | Form 4 ↗ |
| Jul 15, 2026 | Erin Pennock Foff Chief Medical Officer | MPLT MapLight Therapeutics, Inc. | Sale | 8,972 | $36.99 | $331.9K Sale | Form 4 ↗ |
| Jul 15, 2026 | Erin Pennock Foff Chief Medical Officer | MPLT MapLight Therapeutics, Inc. | Sale | 4,465 | $36.00 | $160.7K Sale | Form 4 ↗ |
| Jul 15, 2026 | Erin Pennock Foff Chief Medical Officer | MPLT MapLight Therapeutics, Inc. | Sale | 7,845 | $37.04 | $290.6K Sale | Form 4 ↗ |
| Jul 15, 2026 | Erin Pennock Foff Chief Medical Officer | MPLT MapLight Therapeutics, Inc. | Sale | 7,155 | $36.16 | $258.7K Sale | Form 4 ↗ |
| Jul 15, 2026 | Kristopher Hanson General Counsel | MPLT MapLight Therapeutics, Inc. | Sale | 10 | $37.54 | $375 Sale | Form 4 ↗ |
| Jul 15, 2026 | Kristopher Hanson General Counsel | MPLT MapLight Therapeutics, Inc. | Sale | 5,103 | $36.99 | $188.8K Sale | Form 4 ↗ |
| Jul 15, 2026 | Kristopher Hanson General Counsel | MPLT MapLight Therapeutics, Inc. | Sale | 2,147 | $36.00 | $77.3K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:24 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances